|
|
Blood, 15 January 2006, Vol. 107, No. 2, pp. 725-732.
Prepublished online as a Blood First Edition Paper on September 13, 2005; DOI 10.1182/blood-2005-06-2534.
Previous Article | Next Article 
Submitted June 27, 2005
Accepted September 1, 2005
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas
Grzegorz Sarek, Annika Jarviluoma, and Paivi Ojala*
Molecular Cancer Biology Program, Institute of Biomedicine, Biomedicum Helsinki, Helsinki, Finland
* Corresponding author; email: Paivi.Ojala{at}helsinki.fi.
Kaposi's sarcoma herpesvirus infection is consistently associated with primary effusion lymphomas (PELs) that are non-Hodgkin's lymphomas of B-cell origin. All PEL cells are latently infected with KSHV and express latent viral proteins such as the viral cyclin (v-cyclin), which has previously been implicated in downregulation of the cell cycle inhibitor p27KIP1 levels via phosphorylation on Thr187. PEL cells retain high levels of p27KIP1 but yet proliferate actively, which has left the biological significance of this p27KIP1 destabilization somewhat elusive. We have recently demonstrated that v-cyclin and p27KIP1 stably associate in PEL cells. Here we demonstrate that v-cyclin together with its kinase partner CDK6 phosphorylates the associated p27KIP1 in PEL cells which represent a biologically relevant model system for KSHV pathobiology. During latent viral replication p27KIP1 was phosphorylated by v-cyclin-CDK6 predominantly on Ser10 which enhances its cytoplasmic localization. Interestingly, upon reactivation of KSHV lytic cycle v-cyclin-CDK6 phosphorylated p27KIP1 on Thr187, which resulted in downregulation of p27KIP1 protein levels. These findings indicate that v-cyclin modulates the cell cycle inhibitory function of p27KIP1 by phosphorylation in PELs, and also suggest a novel role for v-cyclin in the lytic reactivation of KSHV.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz
HIV-associated lymphomas and gamma-herpesviruses
Blood,
February 5, 2009;
113(6):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-C. Chang and M. Li
Kaposi's Sarcoma-Associated Herpesvirus K-Cyclin Interacts with Cdk9 and Stimulates Cdk9-Mediated Phosphorylation of p53 Tumor Suppressor
J. Virol.,
January 1, 2008;
82(1):
278 - 290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M-Q Du, C M Bacon, and P G Isaacson
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders
J. Clin. Pathol.,
December 1, 2007;
60(12):
1350 - 1357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Munoz-Fontela, M. A. Garcia, M. Collado, L. Marcos-Villar, P. Gallego, M. Esteban, and C. Rivas
Control of virus infection by tumour suppressors
Carcinogenesis,
June 1, 2007;
28(6):
1140 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jarviluoma, E. S. Child, G. Sarek, P. Sirimongkolkasem, G. Peters, P. M. Ojala, and D. J. Mann
Phosphorylation of the Cyclin-Dependent Kinase Inhibitor p21Cip1 on Serine 130 Is Essential for Viral Cyclin-Mediated Bypass of a p21Cip1-Imposed G1 Arrest.
Mol. Cell. Biol.,
March 1, 2006;
26(6):
2430 - 2440.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|